Inhibitors | Comment | Organism | Structure |
---|---|---|---|
4'-O-methylochnaflavone | interacts with residues Lys157, Leu162, Arg166, Glu167, binding energy -105.2 kcal/mol | Severe acute respiratory syndrome coronavirus 2 | |
acacetin | interacts with residue Tyr264, binding energy -38.7 kcal/mol | Severe acute respiratory syndrome coronavirus 2 | |
amentoflavone | interacts with residues Lys157, Leu162, Arg166, Glu167, Asn267, Thr301, binding energy -129.6 kcal/mol | Severe acute respiratory syndrome coronavirus 2 | |
apigenin | interacts with residues Ala246, Tyr264, binding energy -48.2 kcal/mol | Severe acute respiratory syndrome coronavirus 2 | |
cryptomerin | interacts with residues Lys157, Glu161, Arg166, binding energy -87.9 kcal/mol | Severe acute respiratory syndrome coronavirus 2 | |
cryptomerin B | - |
Severe acute respiratory syndrome coronavirus 2 | |
ginkgetin | interacts with residues Lys157, Leu162, Asp164, Arg166, Gly266, binding energy -117.2 kcal/mol | Severe acute respiratory syndrome coronavirus 2 | |
hinokiflavone | interacts with residues Lys157, Glu161, Asp164, Arg166, Gly266, binding energy -119.1 kcal/mol | Severe acute respiratory syndrome coronavirus 2 | |
isoginkgetin | interacts with residues Lys157, Leu162, Asp164, Arg166, binding energy -123.5 kcal/mol | Severe acute respiratory syndrome coronavirus 2 | |
additional information | discovery, antiviral evaluation, structure-activity relationship elucidation and molecular docking; inhibitors of PLpro are discovered by investigating the national compound library of traditional Chinese medicines, a phytochemical library comprising over 9000 TCM-derived compounds. Through virtual screening and enzymatic evaluations, nine natural biflavones are confirmed to be effective PLpro inhibitors with IC50 values ranging from 0.0095 to 0.0432 mM. Pro-ISG15 cleavage assays demonstrate that several biflavones exhibit potent inhibitory effects against PLpro-mediated deISGylation, a key process involved in viral immune evasion. The discovery, antiviral evaluation, structure-activity relationship elucidation and molecular docking investigation of biflavones as potent inhibitors of SARS-CoV-2 PLpro is reported; investigation of biflavones as potent inhibitors of SARS-CoV-2 PLpro | Severe acute respiratory syndrome coronavirus 2 | |
morelloflavone | interacts with residue Arg166, binding energy -81.6 kcal/mol | Severe acute respiratory syndrome coronavirus 2 | |
podocarpusflavone | interacts with residues Lys157, Leu162, Glu167, Thr301, binding energy -66.2 kcal/mol | Severe acute respiratory syndrome coronavirus 2 | |
podocarpusflavone A | - |
Severe acute respiratory syndrome coronavirus 2 | |
psoralidin | interacts with residue Tyr264, binding energy -55.8 kcal/mol | Severe acute respiratory syndrome coronavirus 2 | |
sciadopitysin | interacts with residues Lys157Lys157, Leu162, binding energy -113.4 kcal/mol | Severe acute respiratory syndrome coronavirus 2 |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Severe acute respiratory syndrome coronavirus 2 | P0DTD1 | SARS-CoV-2 | - |
Severe acute respiratory syndrome coronavirus 2 | P0DTD1 | replicase polyprotein 1ab | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
benzyloxycarbonyl-RLRGG-7-amido-4-methylcoumarin + H2O | - |
Severe acute respiratory syndrome coronavirus 2 | benzyloxycarbonyl-RLRGG + 7-amino-4-methylcoumarin | - |
? | |
Z-RLRGG-7-amido-4-methylcoumarin + H2O | - |
Severe acute respiratory syndrome coronavirus 2 | Z-RLRGG + 7-amino-4-methylcoumarin | - |
? |
Synonyms | Comment | Organism |
---|---|---|
PLpro | - |
Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 papain-like protease | - |
Severe acute respiratory syndrome coronavirus 2 |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0078 | - |
hinokiflavone | pH 8.0, 37°C | Severe acute respiratory syndrome coronavirus 2 | |
0.0078 | - |
hinokiflavone | pH 8, 37°C | Severe acute respiratory syndrome coronavirus 2 | |
0.0091 | - |
amentoflavone | pH 8.0, 37°C | Severe acute respiratory syndrome coronavirus 2 | |
0.0091 | - |
amentoflavone | pH 8, 37°C | Severe acute respiratory syndrome coronavirus 2 | |
0.0143 | - |
cryptomerin B | pH 8.0, 37°C | Severe acute respiratory syndrome coronavirus 2 | |
0.0143 | - |
cryptomerin | pH 8, 37°C | Severe acute respiratory syndrome coronavirus 2 | |
0.0177 | - |
ginkgetin | pH 8.0, 37°C | Severe acute respiratory syndrome coronavirus 2 | |
0.0177 | - |
ginkgetin | pH 8, 37°C | Severe acute respiratory syndrome coronavirus 2 | |
0.0193 | - |
4'-O-methylochnaflavone | pH 8, 37°C | Severe acute respiratory syndrome coronavirus 2 | |
0.0197 | - |
4'-O-methylochnaflavone | pH 8.0, 37°C | Severe acute respiratory syndrome coronavirus 2 | |
0.0236 | - |
sciadopitysin | pH 8.0, 37°C | Severe acute respiratory syndrome coronavirus 2 | |
0.0236 | - |
sciadopitysin | pH 8, 37°C | Severe acute respiratory syndrome coronavirus 2 | |
0.0265 | - |
isoginkgetin | pH 8.0, 37°C | Severe acute respiratory syndrome coronavirus 2 | |
0.0265 | - |
isoginkgetin | pH 8, 37°C | Severe acute respiratory syndrome coronavirus 2 | |
0.0307 | - |
morelloflavone | pH 8.0, 37°C | Severe acute respiratory syndrome coronavirus 2 | |
0.0307 | - |
morelloflavone | pH 8, 37°C | Severe acute respiratory syndrome coronavirus 2 | |
0.0365 | - |
podocarpusflavone A | pH 8.0, 37°C | Severe acute respiratory syndrome coronavirus 2 | |
0.0365 | - |
podocarpusflavone | pH 8, 37°C | Severe acute respiratory syndrome coronavirus 2 |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.0095 | - |
pH 8.0, 37°C | Severe acute respiratory syndrome coronavirus 2 | hinokiflavone | |
0.0095 | - |
pH 8, 37°C | Severe acute respiratory syndrome coronavirus 2 | hinokiflavone | |
0.013 | - |
pH 8.0, 37°C | Severe acute respiratory syndrome coronavirus 2 | amentoflavone | |
0.013 | - |
pH 8, 37°C | Severe acute respiratory syndrome coronavirus 2 | amentoflavone | |
0.0228 | - |
pH 8.0, 37°C | Severe acute respiratory syndrome coronavirus 2 | 4'-O-methylochnaflavone | |
0.0228 | - |
pH 8, 37°C | Severe acute respiratory syndrome coronavirus 2 | 4'-O-methylochnaflavone | |
0.0263 | - |
pH 8.0, 37°C | Severe acute respiratory syndrome coronavirus 2 | cryptomerin B | |
0.0263 | - |
pH 8, 37°C | Severe acute respiratory syndrome coronavirus 2 | cryptomerin | |
0.0278 | - |
pH 8.0, 37°C | Severe acute respiratory syndrome coronavirus 2 | psoralidin | |
0.0278 | - |
pH 8, 37°C | Severe acute respiratory syndrome coronavirus 2 | psoralidin | |
0.0298 | - |
pH 8.0, 37°C | Severe acute respiratory syndrome coronavirus 2 | ginkgetin | |
0.0298 | - |
pH 8, 37°C | Severe acute respiratory syndrome coronavirus 2 | ginkgetin | |
0.0312 | - |
pH 8.0, 37°C | Severe acute respiratory syndrome coronavirus 2 | isoginkgetin | |
0.0312 | - |
pH 8, 37°C | Severe acute respiratory syndrome coronavirus 2 | isoginkgetin | |
0.0348 | - |
pH 8.0, 37°C | Severe acute respiratory syndrome coronavirus 2 | sciadopitysin | |
0.0348 | - |
pH 8, 37°C | Severe acute respiratory syndrome coronavirus 2 | sciadopitysin | |
0.0364 | - |
pH 8.0, 37°C | Severe acute respiratory syndrome coronavirus 2 | morelloflavone | |
0.0364 | - |
pH 8, 37°C | Severe acute respiratory syndrome coronavirus 2 | morelloflavone | |
0.0432 | - |
pH 8.0, 37°C | Severe acute respiratory syndrome coronavirus 2 | podocarpusflavone A | |
0.0432 | - |
pH 8, 37°C | Severe acute respiratory syndrome coronavirus 2 | podocarpusflavone | |
0.0757 | - |
pH 8.0, 37°C | Severe acute respiratory syndrome coronavirus 2 | apigenin | |
0.0757 | - |
pH 8, 37°C | Severe acute respiratory syndrome coronavirus 2 | apigenin | |
0.0912 | - |
pH 8.0, 37°C | Severe acute respiratory syndrome coronavirus 2 | acacetin | |
0.0912 | - |
pH 8, 37°C | Severe acute respiratory syndrome coronavirus 2 | acacetin |
General Information | Comment | Organism |
---|---|---|
drug target | significant suppression of viral spread and promotion of antiviral immunity can be achieved by inhibition of PLpro, revealing an inspiring strategy for COVID-19 treatment | Severe acute respiratory syndrome coronavirus 2 |
physiological function | key enzyme encoded by SARS-CoV-2 that is essential for viral replication and immune evasion | Severe acute respiratory syndrome coronavirus 2 |